Format

Send to

Choose Destination
J Eur Acad Dermatol Venereol. 2015 Jan;29(1):1-6. doi: 10.1111/jdv.12461. Epub 2014 Mar 24.

2013 European guideline on the management of lymphogranuloma venereum.

Author information

1
STI Outpatient Clinic, Cluster Infectious Diseases, Public Health Service Amsterdam, Amsterdam, The Netherlands; Department of Dermatology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; Centre for Infectious Diseases and Immunology Amsterdam (CINIMA), Amsterdam, The Netherlands; Centre for Infectious Disease Control, National Institute of Public Health and the Environment, Bilthoven, The Netherlands.

Abstract

WHAT IS NEW IN THIS UPDATED GUIDELINE?: This is the update version of the 2010 European guideline on the management of lymphogranuloma venereum (LGV). New issues are:

EPIDEMIOLOGY:

Based on clonal relatedness of prevalent LGV strains there is evidence that the LGV epidemic among men who have sex with men (MSM) in the Western world prevailed already in the United States in the 1980s and was introduced into Europe by the end of the last century.

AETIOLOGY AND TRANSMISSION:

A new LGV variant causing severe proctitis was unveiled and designated L2c. The L2b LGV variant causing the vast majority of infections among MSM is now also found among a few heterosexual women.

MANAGEMENT:

Apart from HIV and STI screening, Hepatitis C Virus (HCV) testing should be offered to all LGV patients. To exclude reinfections, STI screening during a follow-up visit 3 months after an LGV diagnosis should be offered.

PMID:
24661352
DOI:
10.1111/jdv.12461
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center